Thermo Fisher Scientific Inc - stock earnings
TMO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 24, 2024 AfterMarket | 5.11 / 4.76 | - | - / 10.3 billion | - |
TMO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 1.6 billion USD | 10.9 billion USD |
| 2023Q3 | 1.7 billion USD | 10.6 billion USD |
| 2023Q2 | 1.4 billion USD | 10.7 billion USD |
| 2023Q1 | 1.3 billion USD | 10.7 billion USD |
| 2022Q4 | 1.6 billion USD | 11.5 billion USD |
| 2022Q3 | 1.5 billion USD | 10.7 billion USD |
| 2022Q2 | 1.7 billion USD | 11.0 billion USD |
| 2022Q1 | 2.2 billion USD | 11.8 billion USD |
| 2021Q4 | 1.7 billion USD | 10.7 billion USD |
| 2021Q3 | 1.9 billion USD | 9.3 billion USD |
| 2021Q2 | 1.8 billion USD | 9.3 billion USD |
| 2021Q1 | 2.3 billion USD | 9.9 billion USD |
| 2020Q4 | 2.5 billion USD | 10.6 billion USD |
| 2020Q3 | 1.9 billion USD | 8.5 billion USD |
| 2020Q2 | 1.2 billion USD | 6.9 billion USD |
| 2020Q1 | 788.0 million USD | 6.2 billion USD |
| 2019Q4 | 1.0 billion USD | 6.8 billion USD |
| 2019Q3 | 760.0 million USD | 6.3 billion USD |
| 2019Q2 | 1.1 billion USD | 6.3 billion USD |
| 2019Q1 | 815.0 million USD | 6.1 billion USD |
| 2018Q4 | 898.0 million USD | 6.5 billion USD |
| 2018Q3 | 709.0 million USD | 5.9 billion USD |
| 2018Q2 | 752.0 million USD | 6.1 billion USD |
| 2018Q1 | 579.0 million USD | 5.9 billion USD |
| 2017Q4 | 528.0 million USD | 6.0 billion USD |
| 2017Q3 | 533.9 million USD | 5.1 billion USD |
| 2017Q2 | 611.6 million USD | 5.0 billion USD |
| 2017Q1 | 551.4 million USD | 4.8 billion USD |
| 2016Q4 | 629.5 million USD | 5.0 billion USD |
| 2016Q3 | 473.5 million USD | 4.5 billion USD |
| 2016Q2 | 516.6 million USD | 4.5 billion USD |
| 2016Q1 | 402.2 million USD | 4.3 billion USD |
| 2015Q4 | 602.6 million USD | 4.7 billion USD |
| 2015Q3 | 476.1 million USD | 4.1 billion USD |
| 2015Q2 | 511.6 million USD | 4.3 billion USD |
| 2015Q1 | 385.1 million USD | 3.9 billion USD |
| 2014Q4 | 601.2 million USD | 4.5 billion USD |
| 2014Q3 | 471.6 million USD | 4.2 billion USD |
| 2014Q2 | 278.5 million USD | 4.3 billion USD |
| 2014Q1 | 543.1 million USD | 3.9 billion USD |
| 2013Q4 | 342.1 million USD | 3.5 billion USD |
| 2013Q3 | 317.6 million USD | 3.2 billion USD |
| 2013Q2 | 277.4 million USD | 3.2 billion USD |
| 2013Q1 | 336.2 million USD | 3.2 billion USD |
| 2012Q4 | 376.4 million USD | 3.3 billion USD |
| 2012Q3 | 290.4 million USD | 3.1 billion USD |
| 2012Q2 | 233.8 million USD | 3.1 billion USD |
| 2012Q1 | 277.3 million USD | 3.1 billion USD |
| 2011Q4 | 288.9 million USD | 3.1 billion USD |
| 2011Q3 | 265.4 million USD | 3.0 billion USD |
| 2011Q2 | 523.4 million USD | 2.9 billion USD |
| 2011Q1 | 252.2 million USD | 2.7 billion USD |
| 2010Q4 | 297.5 million USD | 2.8 billion USD |
| 2010Q3 | 268.5 million USD | 2.7 billion USD |
| 2010Q2 | 237.3 million USD | 2.6 billion USD |
| 2010Q1 | 232.3 million USD | 2.7 billion USD |
| 2009Q4 | 273.3 million USD | 2.8 billion USD |
| 2009Q3 | 221.2 million USD | 2.5 billion USD |
| 2009Q2 | 206.9 million USD | 2.5 billion USD |
| 2009Q1 | 148.9 million USD | 2.3 billion USD |
| 2008Q4 | 290.2 million USD | 2.6 billion USD |
| 2008Q3 | 221.5 million USD | 2.6 billion USD |
| 2008Q2 | 249.5 million USD | 2.7 billion USD |
| 2008Q1 | 233.0 million USD | 2.6 billion USD |
| 2007Q4 | 239.8 million USD | 2.6 billion USD |
| 2007Q3 | 218.5 million USD | 2.4 billion USD |
| 2007Q2 | 163.9 million USD | 2.4 billion USD |
| 2007Q1 | 138.9 million USD | 2.3 billion USD |
| 2006Q4 | 25.3 million USD | 1.7 billion USD |
| 2006Q3 | 48.8 million USD | 725.0 million USD |
| 2006Q2 | 47.9 million USD | 713.5 million USD |
| 2006Q1 | 46.9 million USD | 684.3 million USD |
| 2005Q4 | 56.4 million USD | 740.8 million USD |
| 2005Q3 | 57.7 million USD | 679.4 million USD |
| 2005Q2 | 60.2 million USD | 653.6 million USD |
| 2005Q1 | 48.9 million USD | 559.2 million USD |
| 2004Q4 | 121.1 million USD | 613.3 million USD |
| 2004Q3 | 106.5 million USD | 542.3 million USD |
| 2004Q2 | 91.1 million USD | 525.3 million USD |
| 2004Q1 | 43.1 million USD | 582.0 million USD |
| 2003Q4 | 61.9 million USD | 583.4 million USD |
| 2003Q3 | 48.5 million USD | 497.1 million USD |
| 2003Q2 | 53.1 million USD | 516.4 million USD |
| 2003Q1 | 36.4 million USD | 500.2 million USD |
| 2002Q4 | 87.2 million USD | 568.7 million USD |
| 2002Q3 | 39.0 million USD | 517.2 million USD |
| 2002Q2 | 68.5 million USD | 509.1 million USD |
| 2002Q1 | 115.0 million USD | 491.3 million USD |
| 2001Q4 | -6.9 million USD | 559.7 million USD |
| 2001Q3 | 26.3 million USD | 512.9 million USD |
| 2001Q2 | 25.0 million USD | 542.5 million USD |
| 2001Q1 | -45.2 million USD | 573.1 million USD |
| 2000Q4 | -90.7 million USD | 491.2 million USD |
| 2000Q3 | 13.5 million USD | 581.0 million USD |
| 2000Q2 | 25.3 million USD | 609.5 million USD |
| 2000Q1 | 15.8 million USD | 598.9 million USD |
| 1999Q4 | -4.0 million USD | 659.0 million USD |
| 1999Q3 | 36.3 million USD | 624.3 million USD |
| 1999Q2 | -235.2 million USD | 632.2 million USD |
| 1999Q1 | 28.3 million USD | 555.8 million USD |
| 1998Q4 | 37.0 million USD | 998.4 million USD |
| 1998Q3 | 17.6 million USD | 977.2 million USD |
| 1998Q2 | 61.8 million USD | 947.8 million USD |
| 1998Q1 | 65.5 million USD | 944.3 million USD |
| 1997Q4 | 69.2 million USD | 1.0 billion USD |
| 1997Q3 | 61.9 million USD | 909.9 million USD |
| 1997Q2 | 56.2 million USD | 875.0 million USD |
| 1997Q1 | 52.1 million USD | 763.5 million USD |
| 1996Q4 | 53.6 million USD | 794.5 million USD |
| 1996Q3 | 51.2 million USD | 740.0 million USD |
| 1996Q2 | 44.9 million USD | 745.8 million USD |
| 1996Q1 | 40.4 million USD | 635.1 million USD |
| 1995Q4 | 39.8 million USD | 629.8 million USD |
| 1995Q3 | 38.1 million USD | 570.4 million USD |
| 1995Q2 | 32.6 million USD | 528.7 million USD |
| 1995Q1 | 29.5 million USD | 478.5 million USD |
| 1994Q4 | 29.0 million USD | 433.4 million USD |
| 1994Q3 | 27.7 million USD | 406.5 million USD |
| 1994Q2 | 24.2 million USD | 395.0 million USD |
| 1994Q1 | 22.5 million USD | 350.5 million USD |
| 1993Q4 | 22.6 million USD | 338.1 million USD |
| 1993Q3 | 20.9 million USD | 318.4 million USD |
| 1993Q2 | 17.6 million USD | 300.4 million USD |
| 1993Q1 | 15.4 million USD | 292.8 million USD |
| 1992Q4 | 17.1 million USD | 291.6 million USD |
| 1992Q3 | 15.5 million USD | 242.9 million USD |
| 1992Q2 | 13.9 million USD | 210.1 million USD |
| 1992Q1 | 12.6 million USD | 204.4 million USD |
| 1991Q4 | 14.2 million USD | 220.2 million USD |
| 1991Q3 | 13.6 million USD | 192.0 million USD |
| 1991Q2 | 10.2 million USD | 193.9 million USD |
| 1991Q1 | 8.2 million USD | 191.8 million USD |
| 1990Q4 | 9.9 million USD | 213.5 million USD |
| 1990Q3 | 9.5 million USD | 181.5 million USD |
| 1990Q2 | 8.1 million USD | 170.2 million USD |
| 1990Q1 | 6.0 million USD | 133.3 million USD |
| 1989Q4 | 7.6 million USD | 157.9 million USD |
| 1989Q3 | 6.6 million USD | 133.1 million USD |
| 1989Q2 | ? USD | 150.8 million USD |
| 1989Q1 | ? USD | 137.2 million USD |
| 1988Q4 | ? USD | 150.3 million USD |
| 1988Q3 | ? USD | 125.6 million USD |
| 1988Q2 | ? USD | 121.4 million USD |
| 1988Q1 | ? USD | 103.2 million USD |
| 1987Q4 | ? USD | 78.4 million USD |
| 1987Q3 | ? USD | 109.1 million USD |
| 1987Q2 | ? USD | 95.5 million USD |
| 1987Q1 | ? USD | 93.2 million USD |
| 1986Q4 | ? USD | 88.5 million USD |
| 1986Q3 | ? USD | 85.2 million USD |
| 1986Q2 | ? USD | 79.7 million USD |
| 1986Q1 | ? USD | 78.3 million USD |
| 1985Q4 | ? USD | 69.4 million USD |
| 1985Q3 | ? USD | 63.1 million USD |
TMO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.0 billion USD | 42.9 billion USD |
| 2022 | 7.0 billion USD | 44.9 billion USD |
| 2021 | 7.7 billion USD | 39.2 billion USD |
| 2020 | 6.4 billion USD | 32.2 billion USD |
| 2019 | 3.7 billion USD | 25.5 billion USD |
| 2018 | 2.9 billion USD | 24.4 billion USD |
| 2017 | 2.2 billion USD | 20.9 billion USD |
| 2016 | 2.0 billion USD | 18.3 billion USD |
| 2015 | 2.0 billion USD | 17.0 billion USD |
| 2014 | 1.9 billion USD | 16.9 billion USD |
| 2013 | 1.3 billion USD | 13.1 billion USD |
| 2012 | 1.2 billion USD | 12.5 billion USD |
| 2011 | 1.3 billion USD | 11.7 billion USD |
| 2010 | 1.0 billion USD | 10.8 billion USD |
| 2009 | 850.3 million USD | 10.1 billion USD |
| 2008 | 994.2 million USD | 10.5 billion USD |
| 2007 | 761.1 million USD | 9.7 billion USD |
| 2006 | 168.9 million USD | 3.8 billion USD |
| 2005 | 223.2 million USD | 2.6 billion USD |
| 2004 | 361.8 million USD | 2.2 billion USD |
| 2003 | 200.0 million USD | 2.1 billion USD |
| 2002 | 309.7 million USD | 2.1 billion USD |
| 2001 | -781000 USD | 2.2 billion USD |
| 2000 | -36.1 million USD | 2.3 billion USD |
| 1999 | -174.6 million USD | 2.5 billion USD |
| 1998 | 181.9 million USD | 3.9 billion USD |
| 1997 | 239.3 million USD | 3.6 billion USD |
| 1996 | 190.8 million USD | 2.9 billion USD |
| 1995 | 140.1 million USD | 2.2 billion USD |
| 1994 | 103.4 million USD | 1.6 billion USD |
| 1993 | 76.6 million USD | 1.2 billion USD |
| 1992 | 59.2 million USD | 949.0 million USD |
| 1991 | 47.1 million USD | 805.5 million USD |
| 1990 | 33.9 million USD | 708.0 million USD |
| 1989 | 24.6 million USD | 579.0 million USD |
| 1988 | 20.1 million USD | 500.6 million USD |
| 1987 | 18.1 million USD | 383.4 million USD |
| 1986 | 14.3 million USD | 331.6 million USD |
| 1985 | 9.6 million USD | 265.7 million USD |
TMO
List: Challengers
Price: $573.94
52 week price:
Dividend Yield: 0.00%
5-year range yield:
Forward Dividend Yield: 0.27%
Payout Ratio: 10.21%
Payout Ratio Range:
Dividend Per Share: 1.56 USD
Earnings Per Share: 15.43 USD
P/E Ratio: 35.82
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.2 million
Ebitda: 1.6 billionMarket Capitalization: 215.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR3: 16.53%
DGR5: 15.07%
DGR10: 8.58%